Rod and Cone Mediated Function in Retinal Disease
Launched by NATIONAL EYE INSTITUTE (NEI) · Nov 28, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well people can see in the dark and whether this can help doctors understand the severity of certain eye diseases, like retinal degeneration, retinitis pigmentosa, and Stargardt's disease. The goal is to see if measuring night vision can detect these diseases early and track how they change over time. Researchers are looking for individuals aged 5 and older, including those with retinal diseases and healthy volunteers who can see well (20/20 vision or better in at least one eye).
Participants will go through a detailed screening process that includes eye exams, imaging tests, and special vision tests to assess how their eyes respond to light. The first visit will take several hours, and there may be up to six more visits over the next year. During these visits, participants will undergo various tests, including sitting in the dark to measure their sensitivity to light. It’s important for participants to understand what the study involves and be able to cooperate with the testing. This study aims to improve our understanding of retinal diseases and how they affect vision.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Participant must be five years of age or older.
- • Participant (or legal guardian) must understand and sign the protocol s informed consent document.
- • Participant must be able to cooperate with the testing required for this study.
- For Participants with retinal disease only:
- • Participant must have retinal disease, defined as evidence of loss of retinal dysfunction and/or degeneration as established by standard clinical methods including perimetry, ERG and imaging.
- • Participant must have a measurable visual acuity.
- For Healthy Volunteers only:
- • -Participant must have visual acuity of 20/20 or better, with or without correction (e.g., glasses or contact lens) in at least one eye.
- EXCLUSION CRITERIA:
- • -Participant with changes in pre-retinal media sufficient to obscure a view of the retina.
About National Eye Institute (Nei)
The National Eye Institute (NEI), part of the U.S. National Institutes of Health (NIH), is dedicated to conducting and supporting innovative research to understand, prevent, and treat eye diseases and vision disorders. As a leading sponsor of clinical trials, NEI aims to advance knowledge in ocular health through rigorous scientific inquiry and collaboration with researchers, healthcare professionals, and institutions. By fostering the development of new therapies and technologies, NEI plays a pivotal role in enhancing the quality of life for individuals affected by visual impairments and eye conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Patients applied
Trial Officials
Brett G Jeffrey, Ph.D.
Principal Investigator
National Eye Institute (NEI)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials